Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check7 days agoChange DetectedThe study is no longer looking for participants, indicating recruitment has closed. The record version has been updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.3%

- Check14 days agoChange DetectedThe history view now shows a new revision label v3.5.5, replacing the previous v3.5.4. This reflects a minor platform update to the history metadata rather than any study content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.5.4 replaces the previous revision (v3.5.3) on the page, signaling a backend platform update. It does not modify study data or other user-facing content.SummaryDifference0.1%

- Check56 days agoChange DetectedUpdated the displayed revision/version number on the ClinicalTrials.gov page from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision labeled v3.5.2 was added, and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision history shows the addition of site revision v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.